Cas:3312-04-7 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene manufacturer & supplier

Chemical Name:1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene

CAS.NO:3312-04-7

Synonyms:1,1-bis(p-fluorophenyl)-4-chlorobutane;4,4-bis(4-fluoro-phenyl)-1-chloro-butane;4-chloro-1,1-bis(4-fluorophenyl)butane;1,1-bis (4-fluorophenyl)-4-chlorobutane;EINECS 221-998-6;4-chloro-1,1-bis-(p-fluorophenyl)-butane;MFCD00044723;4,4-bis-(p-fluorophenyl)-butyl chloride;1,1′-(4-Chlorobutylidene)bis(4-fluorobenzene);1-chloro-4,4-bis(p-fluorophenyl)butane

Molecular Formula:C₁₆H₁₅ClF₂

Molecular Weight:280.74000

HS Code:2903999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:365.2ºC at 760mmHg

Density:1.175g/cm3

Index of Refraction:1.541-1.545

PSA:

Exact Mass:280.08300

LogP:5.11570

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,1-bis(p-fluorophenyl)-4-chlorobutane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-chloro-4,4-bis(p-fluorophenyl)butane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4-bis-(p-fluorophenyl)-butyl chloride Use and application,1-chloro-4,4-bis(p-fluorophenyl)butane technical grade,usp/ep/jp grade.

Related News: Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene manufacturer The company��s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients. 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene supplier The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday. 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene factory The company��s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.